{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:28:13Z","timestamp":1793410093268,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.esmoop.2023.101577","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T15:04:09Z","timestamp":1685545449000},"page":"101577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping"],"prefix":"10.1016","volume":"8","author":[{"given":"B.","family":"Royer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ciccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Derain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Parant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.esmoop.2023.101577_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bulcan.2018.02.001","article-title":"Dihydropyrimidine d\u00e9hydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: update and recommendations of the French\u00a0GPCO-Unicancer and RNPGx networks","volume":"105","author":"Loriot","year":"2018","journal-title":"Bull Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101577_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2006.09.006","article-title":"5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency","volume":"249","author":"Boisdron-Celle","year":"2007","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101577_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175998","article-title":"New advances in DPYD genotype and risk of severe toxicity under capecitabine","volume":"12","author":"Etienne-Grimaldi","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101577_bib4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/bjc.2017.94","article-title":"Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity","volume":"116","author":"Meulendijks","year":"2017","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101577_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00228-018-2426-4","article-title":"The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases","volume":"74","author":"Jacobs","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.esmoop.2023.101577_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221148536","article-title":"Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients","volume":"15","author":"Callon","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.esmoop.2023.101577_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.15715","article-title":"Discrepancies between dihydropyrimidine dehydrogenase phenotyping and genotyping: what are the explanatory factors?","author":"Arriv\u00e9","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101577_bib8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.annonc.2022.04.073","article-title":"Clinical considerations for DPD deficiency testing in advanced cancer patients: tumor lysis syndrome should be considered as a major interference","volume":"33","author":"Launay","year":"2022","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101577_bib9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00280-021-04354-7","article-title":"Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results","volume":"88","author":"Gaible","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101577_bib10","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1111\/bcp.15482","article-title":"Renal impairment and DPD testing: watch out for false-positive results","volume":"88","author":"Carriat","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.esmoop.2023.101577_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/bcp.15536","article-title":"Quantitative impact of pre-analytical\u00a0process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency","volume":"89","author":"Maillard","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.esmoop.2023.101577_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115027","article-title":"Quantification of uracil, dihydrouracil, thymine and dihydrothymine for reliable dihydropyrimidine dehydrogenase (DPD) phenotyping critically depend on blood and plasma storage conditions","volume":"221","author":"van den Wildenberg","year":"2022","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101577_bib13","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1016\/j.ekir.2021.05.038","article-title":"Iohexol plasma clearance: impact of weighing the syringe","volume":"6","author":"Delanaye","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101577_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/bcp.12198","article-title":"Measurement of renal function in patients with chronic kidney disease: renal function in CKD","volume":"76","author":"Sandilands","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.esmoop.2023.101577_bib16","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/ndt\/gfy020","article-title":"Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate","volume":"33","author":"Gil","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101577_bib17","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1681\/ASN.2013020126","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"Sharma","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101577_bib18","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/annonc\/mdg302","article-title":"Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunction","volume":"14","author":"Fleming","year":"2003","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101577_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2125.2005.02472.x","article-title":"Physiologically based pharmacokinetic modelling of the three-step metabolism of pyrimidine using 13C-uracil as an in\u00a0vivo probe: PBPK modelling of 13C-uracil in humans","volume":"60","author":"Ito","year":"2005","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101577_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.ftd.0000183384.89275.f4","article-title":"Effect of hemodialysis on the metabolic clearance of 5-fluorouracil in a patient with end-stage renal failure","volume":"27","author":"Gusella","year":"2005","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101577_bib21","doi-asserted-by":"crossref","first-page":"e10.1","DOI":"10.1053\/ajkd.2002.30584","article-title":"Pharmacokinetics of 5-fluorouracil and its catabolites determined by 19F nuclear magnetic resonance spectroscopy for a patient on chronic hemodialysis","volume":"39","author":"Rengelshausen","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101577_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep26138","article-title":"Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling","volume":"6","author":"Kimura","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101577_bib23","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/cts.13203","article-title":"Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase","volume":"15","author":"Kang","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"11 Pt 1","key":"10.1016\/j.esmoop.2023.101577_bib24","first-page":"5553","article-title":"Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase","volume":"45","author":"Tuchman","year":"1985","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101577_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100125","article-title":"Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature","volume":"6","author":"Hodroj","year":"2021","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.esmoop.2023.101577_bib26","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3390\/pharmaceutics14102119","article-title":"Impact of guidelines regarding dihydropyrimidine dehydrogenase (DPD) deficiency screening using uracil-based phenotyping on the reduction of severe side effect of 5-fluorouracil-based chemotherapy: a propension score analysis","volume":"14","author":"Laures","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923008098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923008098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:30:58Z","timestamp":1761856258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702923008098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2059702923008098"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101577","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101577"}}